Guangzhou, China – From June 1 to June 3, MicroPort® Orthopedics attended the Sixth Chinese Knee Society Conference ("CKS 2018") and displayed its Medial Pivot Knee System with unique design, which attracted wide attention from the attendees. The CKS 2018 was hosted by Chinese Medical Doctor Association and Chinese Association of Orthopedic Surgeons. Around 1,000 orthopedic surgeons were gathered in the congress to exchange ideas on the natural course of knee osteoarthritis, kinesiatrics, total knee/hip replacement, the application of smart instrument, and etc.
In the congress, MicroPort® Orthopedics hosted a satellite meeting on the design rationale and clinical application of medial pivot knee, and invited Professor Haishan Wu of Shanghai Ninth Hospital to give a lecture about "Patient Satisfaction – A Brief Analysis of the Design Rational of Medial Pivot Knee". Professor Wu explained in detail the importance of medial pivot design in restoring the natural knee structure based on the knee anatomy and the results of clinical studies. He said, the medial pivot knee design duplicates the movement of a natural knee and achieve the maximum restoration of the patient’s knee function. Afterwards, Professor Wu introduced MicroPort® Orthopedics’ EVOLUTION™ Medial Pivot Knee System, interpreted the application of the medial pivot philosophy in of knee prosthesis design, and demonstrated the excellent performance of medial pivot knee in terms of patient satisfaction, postoperative knee movement, prosthesis survivorship, and wear-limiting design. He said: "The Medial Pivot Knee is a very successful prosthesis. I love using this product because it truly can improve patient satisfaction."
MicroPort® Orthopedics Medial Pivot Knee was launched in the US in 1998 with around 20 years' clinical history. Up to date, nearly 600,000 Medial Pivot Knees have been implanted globally. Several long-term studies have proved the advantages of medial pivot knee in total knee arthroplasty ("TKA"). The Knee has published a study evaluating long-term clinical and radiographic outcomes of the Medial-Pivot Knee System. The results demonstrate excellent clinical outcomes for both satisfaction (95%) and survivorship (98.8%) at 17 years. In the CKS 2018, MicroPort® Orthopedics staff enhanced the communication with physicians in the hope of keeping improving its products based on their clinical needs, and thereby to build a brand reflecting "the Patient Always Comes First".
About MicroPort®
MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 12 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.
For more information, please refer to: www.microport.com
Forward-Looking Statements
Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.
This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.
All rights reserved.
Copyright © 1998-2018 MicroPort Scientific Corporation
Source: http://www.microport.com